The CSI Conference (Congenital and Structural Heart Disease Intervention Conference) is the top academic conference in the field of cardiovascular disease intervention therapy worldwide. The CSI Conference focuses on innovation and cutting-edge science in the field of cardiovascular disease intervention therapy. It gathers authoritative experts and well-known companies in the global cardiac intervention field to share and exchange experiences in interventional therapy for congenital heart disease, structural heart disease, and valve diseases. The conference also explores innovation and surgical methods in cardiac implantation and interventional medical devices, aiming to promote the long-term development of global cardiac intervention therapy technology through in-depth academic exchanges.
On November 16, 2019, the CSI Conference was held in Frankfurt, Germany. Pulse Medical Company, as an excellent R&D and production enterprise of minimally invasive interventional treatment medical devices for cardiovascular and cerebrovascular diseases, was invited to participate in this international cutting-edge academic event. The CSI conference released the results of the multi center clinical trial of the Lefear pulse medical occluder system, which received high praise and widespread recognition from experts from various countries attending the conference.